Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Corp Highbridge currently holds 81,552 shares of ENZON PHARMACEUTICALS INC (ENZN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Corp Highbridge has been a net buyer of ENZN stock. They have purchased $1.5M and sold $0 worth of shares.
Capital Corp Highbridge's most recent insider trade was on Mar 2, 2007, when they sold 30,000 shares at $8.26 per share.
Capital Corp Highbridge serves as Executive at ENZON PHARMACEUTICALS INC (ENZN). They have executed 22 insider transactions totaling $1.5M over their tenure at the company.
Capital Corp Highbridge holds the position of Executive at ENZON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Capital Corp Highbridge has shown a buying trading pattern, with $1.5M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Corp Highbridge was on Mar 2, 2007, when they sold $349.2K worth of ENZN shares. This transaction involved 40,000 shares at $8.73 per share.
Capital Corp Highbridge currently owns 81,552 shares of ENZON PHARMACEUTICALS INC (ENZN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Corp Highbridge's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Corp Highbridge has 22 Form 4 filings on record as an insider at ENZON PHARMACEUTICALS INC.
Set alerts for Capital Corp Highbridge and 40,000+ other insiders.